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Abstract
Evaluation of nutrition status is imperative for pediatric oncology patients due to the
prevalence of malnutrition and its effects. Methods used to evaluate nutrition status over- and
underestimate energy needs. The purpose of the project was to determine if the Medgem® and
WHO predictive equations predict resting energy expenditure (REE) when compared to a
traditional indirect calorimeter. Participants, 7-18 years of age, had testing completed on a
traditional indirect calorimeter, Medgem®, and energy estimation by WHO equation. Post hoc
pairwise comparisons revealed all three methods were significantly different from one another
(all p<0.0001), suggesting REE be measured by metabolic cart.
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CHAPTER 1
INTRODUCTION
Evaluation of nutrition status is very important for critically ill children, especially
pediatric oncology, because of the prevalence of malnutrition and its effect on growth,
development, clinical outcomes, resource utilization, morbidity, and mortality. 1-9 Several studies
report that 6%-51% of hospitalized children and 8%-60% of pediatric oncology patients
experience illness-related malnutrition, which according to Mehta et al. is most likely under
recognized. 4,10 Nearly half of all pediatric oncology patients receiving treatment experience
malnutrition at least once. 10 The occurrence of malnutrition varies with disease state, but patients
with medulloblastoma showed the highest occurrence and the longest duration of malnutrition.
2,10,11

Factors that may contribute to the under recognition and the variances of the prevalence of

malnutrition and its impact on clinical outcomes include; lack of uniform definitions, varied
nutrition screening practices and failure to prioritize nutrition as part of patient care. 4,12-14 Even
though there is lack of agreement in the identification methods and incidences of malnutrition,
healthcare providers agree that provision of adequate energy is critical during pediatric oncology
treatment.
Indirect calorimetry is the most commonly used method to measure resting energy
expenditure of pediatric patients with different disease states ranging from obese to critically ill
oncology patients. 6,15-19 The “gold standard” for assessing resting energy expenditure (REE) is
via the traditional indirect calorimeter, also known as the metabolic cart (IC). 16,20 However, the
high cost, frequent repairs, burden of time consumed, difficult calibration, and requirement of
trained technicians make the metabolic cart impractical for clinical use. 17,18,21,22
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Predictive equations are often used to estimate REE due to the limited availability
indirect calorimetry. 17,18,21,22 There are more than 200 predictive equations that can be used to
measure energy expenditure. 15,22,23 Unfortunately, many of these equations have proven to be
poor measures of actual needs in critically ill children. 17,18,24 Estimates of energy needs from
predictive equations have an error range of 7%-55% when compared to measured values. 15 The
predictive equations are especially difficult to use in the clinical setting because they are not
disease specific and they are based on the assumption that weight is reflective of body
composition, which does not always hold true due to varying muscle and fat status between
patients. 15,18,22 Some confounding variables that increase the difficulty of uniformly applying
prediction equations to all critically ill populations include; obesity, cachexia, edema and
numerous surgical or metabolic insults 15 Although predictive equations are the least expensive
and most practical for estimating energy requirements, their inaccuracy calls into question their
use in the clinical setting.
A new portable indirect calorimeter that measures REE has begun to be used by some
health care providers. These portable indirect calorimeters are inexpensive, have Food and Drug
Administration (FDA) approval and might be of value in the clinical setting due to its portability,
lesser degree of technicality and cost-effectiveness when compared to the IC device. 22 . To date,
these devices have been validated in adults and healthy-weight children but have not been
evaluated for use in the pediatric oncology population. 22,25,26 The purpose of the quality
improvement (QI) project was to determine if hand-held portable indirect calorimeters and
predictive equations accurately predict energy requirements when compared to the IC.
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CHAPTER 2
METHODOLOGY 27
This QI project recruited participants from October 1 st, 2015 to June 30th, 2016 at St. Jude
Children’s Research Hospital. The participants were pediatric oncology patients aged 7-18 years,
with a weight greater than or equal to 15 kg. Eligible participants met the following
requirements: able to read/speak English, not on supplemental oxygen, not on ventilator support,
no evidence of neuromuscular disorder, did not received general anesthesia within 6-8 hours of
measurement, not on hemodialysis, did not undergo any painful procedures within one hour of
energy measurement, did not have a chest tube, did not require gastric decompression, did not
have a nasal feeding tube and did not receive analgesics or sedatives within 30 minutes prior to
measurement. The International Review Board (IRB) at St. Jude Children’s Research Hospital
waived IRB approval for the QI project because it did not include personal identifiable
information and there was no risk associated with the project.
Indirect Calorimetry
Metabolic cart
Indirect calorimetry by the metabolic cart (IC) included a pneumotachograph, gas
analyzers, display monitor, computer and printer. The system measured breath-by-breath indices
of oxygen consumption (VO2), carbon dioxide production (VCO2), respiratory quotient (RQ),
and resting energy expenditure (REE). The patient’s information (gender, weight, height, and
age) and any current environmental factors were input into the system prior to the measurement.
Measurements were taken via a mouthpiece with the Ultima Cardiopulmonary Gas Exchange
System (Medical Graphics Corporation, Minneapolis, Minnesota). The Ultima system includes
the following equipment: a preVent™ Pneumotach matched with a variable reluctance pressure
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transducer (calculates a factor used to convert flow to volume), a zirconia fuel cell oxygen
analyzer and an infrared carbon dioxide analyzer. All equipment was calibrated by a rigorous,
standardized procedure prior to each use by a qualified pulmonary technician. During calibration
the pneumotachograph sends signals to the waveform analyzer that verifies output and volume
for each breath. The gas analyzer calibrates using room air and calibration gas (12% oxygen, 5%
carbon dioxide, and a nitrogen balance).
Respiratory quotient (RQ) was used as a test of validity for the IC. 23,28 The RQ from the
IC for each patient was recorded and compared to the physiological range that exists in humans:
0.67 to 1.3. 23 Values that were measured outside of this range were presumed to be an error in
calibration, leak in the system or artifactual influence. 28
Hand Held Portable Indirect Calorimeter.
Measurements were made using the Medgem® (MG) via a mouthpiece provided by
Microlife Medical Home Solutions, Inc. The handheld device measures VO 2 and determines
REE using a modified version of the Weir equation with a constant RQ of 0.85, which has a
maximum error of plus or minus 2.2%. 21,29 In clinical settings, RQ typically averages 0.85. It is
extremely rare even under pathophysiologic conditions for an individual’s RQ to be outside the
range of 0.75 and 0.95. 28 VCO2 is not included in the final measure. When the device is turned
on it immediately begins to self-calibrate to room conditions of temperature, barometric pressure
and humidity, no operator input is necessary.
REE testing for each device
Both measures of indirect calorimetry were randomly performed, alternating between the
two from patient to patient, with both being completed within 30 minutes of each other following
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the same procedure parameters. Patients were instructed to be fasting, except for water and
medications, after midnight the night before the study.
Prior to each test, participants were asked if they had adhered to the testing protocols
previously described; patients were escorted to the pulmonary lab at 7:00 am and rested for 30
minutes in a supine position in a quiet, darkened, thermo-neutral room. The patient continued to
lie in a supine position for the duration of both tests.
The trained pulmonary technician conducted the IC test. The first five minutes of the test
were not included to allow the patient time to reach a steady breathing rate. After completion of
the test, the pulmonary technician accounted for any outliers that might disrupt accuracy
including patient movement, coughing, etc. that should be removed from the final total REE
measurement. The modified Weir equation was used to calculate energy equivalency from the
VO2 and VCO2.
Trained members of the Clinical Nutrition Services (CNS) performed the MG test. The
MG test took approximately 10 minutes while participants breathed normally into a mouthpiece
with a nose clip in place, in which the first two minutes were not included to allow the patient to
reach a steady breathing rate.
Predictive equations used to estimate REE
A member of CNS calculated the equation on the same day that the IC and MG were
performed. The World Health Organization (WHO) predictive equations for ages 3-10 years and
10-18 years were used to predict the REE in calories per day in the study population of 7-18 year
olds. 30 The equations take into account patient’s weight in kilograms, age, and gender.
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World Health Organization equation (ages 3-10) 30
Male: (22.7 x wt) + 495
Female: (22.5 x wt) + 499
World Health Organization equation (ages 10-18):
Male: (17.5 x wt) + 651
Female: (12.2 x wt) + 746
Statistical Analysis
Patient demographic and clinical characteristics were summarized by descriptive
statistics (number and percent, mean and standard deviation, or median and range). A two-way
analysis of variance was used to examine overall differences between three methods used to
measure resting energy expenditure (REE). Only main effects were considered, the subject effect
and method effect. An overall F-test was conducted with a significance level of p<0.05 followed
by pairwise comparisons. A two-sided significance level of p<0.05 was used for all pairwise
statistical tests. An equivalence analysis with a significance level of p<0.05 was used to test if
the mean percent difference of REE was between -10% and 10%. Two differences were
considered, which include the mean percent difference between the Medgem® (MG) and the
metabolic cart (IC), and that between the WHO energy equation and the IC. All statistical
analyses were conducted using SAS Version 9.4 (SAS Institute, Cary, NC).
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CHAPTER 3
RESULTS
Description of Patient Population
Demographic and clinical characteristics are summarized for all participants (n = 40) in
Table 1. Patients were a mean age of 13.7 years (SD=3.1), 55% male, and 50% diagnosed with a
solid tumor. Although there was a total number of 40 participants, only 36 completed the
Medgem® (MG). Four patients were unable to complete the MG measurement. Two of the
patients were too restless to complete the MG, and the other two patients completed the
metabolic cart (IC) but were not eligible to complete the MG because the time between the two
measures exceeded 30 minutes. In addition, the RQ’s were within the acceptable limits of 0.67
and 1.3; therefore, no data was excluded due to procedural error.
Comparison of Methods
The results of the two-way ANOVA revealed significant differences between subjects’
mean responses (p<0.0001) and also between methods used (p<0.0001) (Table 2). Post hoc
pairwise comparisons revealed that all three methods were significantly different from one
another (all p<0.0001, Table 3).
The results of the equivalence analysis are shown in Table 4. The average REE value of
the MG method was 11.9% (90% CI: -16.4 to -7.5%) lower that of the IC method. The 90%
confidence limits are not contained within the equivalence bounds -10% and 10%; thus we do
not have sufficient evidence of equivalence between the REE values of the IC and MG methods
as indicated by the overall p-value of 0.764. The average REE values of the WHO predictive
equation method was 12.4% (90% CI: 8.4% to 16.4%) higher that of the IC method. The 90%
confidence limits are not contained within the equivalence bounds -10% and 10%; thus we do
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not have sufficient evidence of equivalence between the REE values of the IC and the WHO
predictive equation methods as indicated by the overall p-value of 0.838.
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CHAPTER 4
DISCUSSION
Indirect calorimetry via metabolic cart is the most commonly used method to measure
energy expenditure of pediatric patients in different populations ranging from obese to critically
ill oncology patients. 6,15-19 While predictive equations and portable indirect calorimetry has been
validated for use in a variety of populations this is the first time, to our knowledge, that the
accuracy of these methods was evaluated in the pediatric oncology population. 16,20-22,25,26 The
current QI project demonstrated significant differences when comparing the Medgem® (MG)
and predictive equations against the traditional indirect calorimeter (IC). When compared to the
IC, the MG on average underestimated REE, while the predictive equations overestimated REE.
There have been many studies on the reliability of hand-held indirect calorimeters;
however, there are conflicting outcomes results. Consistent with our results, Woo et al. recently
published a study revealing that the MG consistently underestimated REE in the overweight and
obese adolescent population. 31 Woo recommended that the MG device not be routinely used;
however, considering that the device habitually underestimated REE, the MG may be clinically
acceptable when used with caution. 31 Anderson et al. tested the MG in overweight and obese
adults and compared the results to those obtained from traditional indirect calorimeter. They
found that the MG systematically overestimated REE when compared to the traditional indirect
calorimeter. Although the MG was found to overestimate REE in adult overweight and obese
individuals, the recommendations for use were similar to those proposed by Woo. Thus, they
concluded that the use of traditional indirect calorimetry is preferred in this population when
managing weight loss and weight maintenance. 32 Different hand-held calorimeters have been
tested and found to be reliable and accurate. One tool, called the KORR ReeVue, studied by
Henes et.al. in overweight and obese adolescents, found that it was a reliable and accurate tool
9

when compared to traditional indirect calorimetry. 16 There were no significant differences
between the two devices. Unlike other portable indirect calorimeters, the KORR ReeVue is not
hand-held by the patient and assumes an RQ of 0.83 with the Weir equation that is used for
metabolic rate calculation. 16 The variations in design and use between ReeVue and the
Medgem® may explain the conflicting results that were found by Woo et al., who also studied
the population of overweight and obese adolescents. 31
The implications of data from studies on REE are extremely significant in the clinical
setting. Pediatric oncology patients that are underfed may become malnourished, increasing their
risk for morbidity and mortality. 7-9,33-38 A study conducted at The University of Texas MD
Anderson Cancer Center revealed that 86% of critically ill oncology patients were either underor over-fed based on predictive equations when compared to traditional indirect calorimetry. 37,39
Underfeeding may result in poor growth and development, decreased wound healing, increased
infection rates, increased resource utilization, decreased therapeutic response, duration of
mechanical ventilation, and increased length of stay. 7-9,33-38
Conversely, overfeeding critically ill patients can lead to adverse events as well. During
treatment some patients may develop hyperglycemia, hepatic dysfunction, prolonged mechanical
ventilation, and fluid overload. 37 In addition, pediatric oncology patients have increased risk of
becoming obese following treatment. 40-45 The exact cause for this is speculative; however, a
study by Zhang, et al evaluated total energy expenditure (TEE) in pediatric oncology survivors
and found that total energy expenditure (TEE) was nearly 500 kcals/day lower than estimated
energy requirements. 45 Zhang et al. suggested that obesity in this patient population might be
related to their reduced total energy expenditure. 45 This energy gap may be addressed by
promoting increased physical activity with a combination of accurate dietary modifications. To
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avoid such adverse events related to under- and over-feeding, precise measures of energy needs
such as indirect calorimetry should be used.
Most clinical dietitians base caloric targets off of estimations derived from one of several
equations. However, predictive equations tend to overestimate caloric needs and do not account
for individual variance. On the other hand, it has been agreed on that traditional indirect
calorimetry is the gold standard for measuring REE and can be used to base caloric needs. 16
Unfortunately, traditional indirect calorimetry is expensive, time-consuming, and not readily
available in the clinical setting. Portable indirect calorimetry offers a more affordable and userfriendly alternative to traditional indirect calorimetry, and a more precise alternative to predictive
equations. Some hand-held portable indirect calorimetry devices have been studied in various
populations; however, there are conflicting reports on their validity. 20,22,25,31,32 The results of this
QI project indicates that this specific hand-held indirect calorimeter may not be a reliable tool to
routinely use when determining energy needs for critically ill children.
A limitation of this QI project was the small sample size yet it is the first project assess
the reliability of the Medgem® in a pediatric oncology setting. It is recommended that further
research be conducted to include a wider range of variables such as disease type and severity,
time in treatment, and nutrition status. Most of our participants were within a healthy, normal
weight range. In addition, a larger sample size would strengthen the evidence of our results.
Also, the intensity of treatment was recorded, but was not evaluated to determine if it had an
effect on the child’s performance during the test or on their REE. Therefore, it would be worth
exploring further how these variables impact REE measurement with the different tools and
equations in this population.
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In conclusion, the results of this QI project determined that the MG routinely
underestimates REE when compared to traditional indirect calorimetry, which is the gold
standard, in a pediatric oncology population. In addition, WHO predictive equations routinely
overestimate REE when compared to traditional indirect calorimetry in the same population.
Thus, both predictive equations and the MG portable hand-held indirect calorimetry should be
used with caution in pediatric oncology population.
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APPENDIX A
REVIEW OF LITERATURE
Evaluation of nutrition status is crucial for critically ill children, especially the pediatric
oncology population, because of the prevalence of malnutrition and its effect on growth,
development, clinical outcomes, resource utilization, morbidity, and mortality. 1,2,4-9,38 The
American Society for Parenteral and Enteral Nutrition (ASPEN) defines pediatric malnutrition as
“an imbalance between nutrient requirement and intake, resulting in cumulative deficits of
energy, protein or micronutrients that may negatively affect growth, development and other
relevant outcomes.” 46
The onset of malnutrition in critically ill patients is controversial. The etiology of
malnutrition may be illness related, caused by environmental/behavioral factors associated with
decreased nutrient intake or delivery, or a combination of the two. 4 Anorexia alone cannot
explain the development of malnutrition because some patients maintain excellent intake but still
suffer from progressive weight loss. 5 Research suggests that although the resting energy
expenditure (REE) of weight loss and weight stable patients is similar, some cases revealed that
the acute-phase proteins were different. It is strongly suggested that acute-phase response (APR)
contributes to weight loss through enhancing REE. 47,48 In addition, the predictive equations,
such as the World Health Organization (WHO) or Harris-Benedict, were found to be in poor
agreement with indirect calorimetry in critically ill children. 17,18 Even though there is lack of
agreement in identification methods and the numbers of incidences of malnutrition, healthcare
providers agree that provision of adequate energy is critical during pediatric oncology treatment.
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Definition of - Malnutrition
Over the past three decades, the definition of malnutrition has evolved. Malnutrition,
which was typically observed in developing countries as marasmus and/or kwashiorkor, is now
being recognized in developed countries as occurring in the setting of acute or chronic illness. 46
In the United States, malnutrition is most frequently observed in hospitalized acute and/or
chronically ill children. 46 Several studies report that 6%-51% of hospitalized children and 8%60% of pediatric oncology patients experience illness-related malnutrition, which according to
Mehta et al. is most likely under recognized. 4,10 Factors that may contribute to this under
recognition of the prevalence of malnutrition and its impact on clinical outcomes include lack of
uniform definitions, varied nutrition screening practices, and failure to prioritize nutrition as part
of patient care. 4,12-14
According to the literature, malnutrition is often assessed by body mass index (BMI) for
age z-scores, fat mass (FM) and fat-free mass (FFM), weight for length or height (WT/LT),
percentile ideal body weight for height of length (%BMI), mid-upper arm circumference, and
hand-grip strength. 1,2,11,46,49,50 Although there is lack of consistency in the classification of
malnutrition, data clearly indicates that the provision of adequate energy is of extreme
importance in the pediatric oncology population to promote optimal growth and development. 6
Acute and chronic malnutrition can result from states of over- and underfeeding and
cause deficits of energy, protein, or micronutrients and may have negative outcomes. Suggested
outcomes of malnutrition include diminished growth and development which are evidenced by
anthropometric measures (height, weight, and head circumference), lean body mass, muscle
strength, and age-appropriate developmental milestones. 4 Further consequences of malnutrition
include impaired immune function, increased infection rate, delayed wound healing, increased
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length of hospital stay, increased disease-specific resource utilization, decreased treatment
tolerance, and decreased survival rate. 2,4,7-9,38,51-54
Prevalence of Malnutrition
The prevalence of malnutrition in pediatric patients has been shown to vary with disease
state; in fact, 8%-60% of pediatric oncology patients experience illness-related malnutrition. 10
Furthermore, nearly half of pediatric oncology patients receiving treatment experience
malnutrition at least once. 10 Although the occurrence of malnutrition varies, patients with
medulloblastoma showed the highest occurrence and the longest duration of malnutrition. 2,11 The
prevalence of malnutrition in the pediatric neuroblastoma population is up to 50%. 2,11,55 Patients
who have been diagnosed with leukemia have the lowest prevalence of malnutrition, with 5%10% at diagnosis and 0%-5% during treatment. 2,11 There is insufficient data on the prevalence of
malnutrition in solid tumor patients; however, it is estimated that 0-30% of children with solid
tumors are at risk for malnutrition at diagnosis or during treatment, which is slightly higher than
leukemia patients. 2,11
Risk Factors for Malnutrition
The etiology of weight loss and malnutrition in pediatric oncology is variable and further
research is encouraged. However, due to the prevalence of malnutrition, it is essential to
understand and recognize possible risk factors. Possible causes of malnutrition include energy
deficiency due to poor intake, increased metabolic rate, altered physical activity, and
inflammation which lead to loss of fat and fat free mass. 2,11 At this time, it is unclear whether or
not pediatric oncology patients have an increased metabolic rate. 11 The metabolic rate of an
oncology patient may be more related to the site of cancer rather than the degree of the tumor

21

burden. 56,57 Other minor factors that could increase the risk of malnutrition during treatment
include enhanced losses due to vomiting, diarrhea, and malabsorption. 11
Consequences of Malnutrition
Patients that are malnourished can experience acute, chronic, and even life threatening
conditions if they are not treated with proper interventions. Pediatric oncology patients that are
malnourished, before or during treatment, may have a decreased tolerance to treatment or have
an unfavorable response to chemotherapy. 2,5,10,54,58,59 Furthermore, there may be an increased
risk of infection. 2,10,38,51-53 Infection can lead to a delay in treatment, thus lowering survival
chances. A study by Loeffen et al., on a large, heterogeneous pediatric oncology population
found that pediatric oncology patients who were malnourished at diagnosis or at three months
after diagnosis had significantly worse survival rates. 38 Additional studies have confirmed this
outcome. 2,7-9,54,60-63 An understanding of a patient’s energy requirements will enable the dietitian
and the primary healthcare team to prevent over- and underfeeding and promote optimal health
for the patient.
Methods of Determining Energy Requirements
Indirect Calorimetry
Thus far, a uniform definition of malnutrition has not been determined. However, studies
that have measured the accuracy of indirect calorimetry methods have concluded that
determining a patient’s energy requirement is beneficial for providing adequate nutrition and
preventing malnutrition. 16,21,25 Indirect calorimetry is the most commonly used method to
measure energy expenditure of pediatric patients in different populations ranging from obese to
critically ill oncology patients. 6,15-19 Indirect calorimetry measures energy expenditure or 24hour caloric requirements reflected by the resting energy expenditure (REE) and substrate
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utilization known as the respiratory quotient (RQ). 22,28 The RQ is a reflection of the subjects’ use
of fat, protein, or carbohydrates, at a cellular level. 28 The physiological range for respiratory
quotient (RQ) in humans exists between 0.67 and 1.3. An RQ of less than 0.82 suggests
underfeeding and lipid catabolism, while an RQ greater than 1.0 indicates excessive carbon
dioxide (CO2) production suggesting overfeeding, potential lipogenesis, and increased
respiratory demand. 23,28 Values that are measured outside of this range can be presumed to be an
error in calibration, leak in the system, or artifactual influence. 28
The body’s ability to use individual nutrient substrates may be altered due to stress or
disease status. 28 Metabolic causes of an RQ less than 0.71 include oxidation of ethanol and
ketones, lipolysis, underfeeding, diabetes mellitus, ketoacidosis, or high rates of urinary glucose
excretion. 23,28 On the other hand, metabolic causes of an RQ greater than 1 include excess CO 2
production, exogenous buffering agents such as sodium bicarbonate, lipogenesis, and
overfeeding. 23 It should also be noted that intensified CO2 release related to tumor burden may
cause an RQ that is greater than 1.5. 64
Indirect calorimetry is beneficial because it can be used to design individualized nutrition
regimens that meet the patients’ exact requirements. Another advantage of using indirect
calorimetry is the potential of cost savings by avoiding overfeeding. One study theoretically
reduced the cost of nutrition support by 22% by reducing the amount of unnecessary parenteral
nutrition (PN). 56,65 One of the most important uses of indirect calorimetry is evaluation of the
effect of cumulative energy balance on patient outcome. A study on critically ill patients
compared daily calories from PN with the energy expenditure measured daily by indirect
calorimetry. 56,66 It was found that patients who demonstrated a positive energy balance (caloric
provision greater than energy expenditure) had a mortality rate of 26.6%. 56,66 In contrast, those
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patients that developed cumulative energy deficits (calories expended minus calories provided)
of more than 10,000 calories had an associated mortality rate of 76.4%. 56,66 This study indicates
that accurate measures of energy expenditure would be beneficial, and in some cases may
prevent mortality.
Thus far, a uniform definition of malnutrition has not been determined. Studies that have
measured the accuracy of indirect calorimetry methods have concluded that determining a
patient’s energy requirement is beneficial for providing adequate nutrition and preventing
malnutrition. 16,21,25 Energy requirements via indirect calorimetry can be performed in three
ways: Traditional indirect calorimetry (Metabolic cart), Hand-held portable indirect calorimetry
(MedGem®), and predictive energy equations.
Tools for Measuring Indirect Calorimetry
Traditional Indirect Calorimetry - Metabolic Cart
The metabolic cart (IC) is known as the gold standard for measuring resting energy
expenditure (REE). 16 The IC device measures the oxygen consumed (VO 2) and the carbon
dioxide (VCO2) produced by the subject, and then the computer system uses the modified Weir
equation to calculate the REE, which is the universal standard for the conversion of gas exchange
measurements into resting energy expenditure. 22 The entire process takes about thirty minutes,
with the first ten minutes used for reaching a steady state of breathing. 21
The metabolic cart may be the gold standard, but it is not without fault. Erroneous results
can be caused by air leaks, fluctuating fraction of inspired oxygen, high pain level, and
inappropriate calibrated equipment. The high cost, frequent repairs, burden of time consumed,
difficult calibration and requirement of trained technicians make the metabolic cart impractical
for clinical use. 16,21,22
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Hand-Held Indirect Calorimeter – MedGem®
A less expensive method of assessing REE can be performed by the portable, FDA
approved hand-held indirect calorimeter device known as the MedGem® (MG), distributed by
MicroLife Medical Home Solutions. Due to the inconvenience of the IC, it is suggested that the
portability and ease of the MG may be beneficial in the clinical setting. As the individual holds
the MG and breaths into a mouthpiece, the device measures only VO 2, where RQ is assumed to
be 0.85. 22 Similar to the IC, the hand-held device determines REE by using the abbreviated Weir
Equation. 15,21,22
The MG is suggested to be of value in the clinical setting due to its portability, lesser
degree of technicality, and cost-effectiveness when compared to the IC. 22 Limitations to the MG
device include measurements in the supine position, undetected air leaks, and the assumed RQ.
22,67,68

Prediction Equations
Predictive equations are often used to estimate REE due to the limited availability of
direct and indirect calorimetry. 15,17,18,22,23,47 There are more than 200 predictive equations that
can be used to measure energy expenditure, some of which include the Harris-Benedict, MifflinSt Jeor, Schofield, Penn State, Ireton-Jones, calories/kg, and World Health Organization (WHO)
energy equations. 22,23 Predictive equations are usually derived from healthy subjects during
resting metabolism, and then added stress or injury is factored into the equation. 15,17,18
Unfortunately, these equations have proven to be poor measures of actual needs in critically ill
children. 17,18,24 Estimates of energy needs from predictive equations have an error range of 755% when compared to measured values. 15 The predictive equations are especially difficult to
use in the clinical setting because they are not disease specific and they are based on the
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assumption that weight is reflective of body composition, which does not always hold true. 15,18,22
Some confounding variables that increase the difficulty of applying prediction equations include
obesity, cachexia, edema, and multiple surgical or metabolic abuses. 15 Although predictive
questions are the least expensive and most practical for estimating energy requirements, their
inaccuracy calls into question their use in the clinical setting.
Conclusion
Further studies need to be done to determine reliability of the MedGem® and the
predictive equations in hospitalized and critically ill patients. Despite the large volume of
research in pediatric oncology, there are still knowledge deficits in regard to malnutrition. 38,46
Standards of etiology, frequency, and outcomes of malnutrition are still being determined.
Malnutrition puts pediatric oncology patients at risk for mortality and bacterial infections; thus, it
is important to determine accurate energy expenditure to prevent over- and underfeeding in
critically ill children. 7-9,38 Having access to reliable tools to measure energy expenditure is vital
in the pediatric oncology clinical setting. The three tools that are commonly used for measuring
resting energy expenditure all have positive and negative attributes that should be compared and
analyzed to determine which tool will most improve nutrition interventions that are specific to
the population of pediatric oncology. Therefore, the purpose of the quality improvement (QI)
project is to determine if the MG and predictive equations accurately predict energy
requirements when compared to the IC. The clinical relevance of this study is related to the
importance of accurately measuring energy expenditure to prevent over- and underfeeding in
pediatric oncology patients, because malnutrition can lead to acute and chronic conditions, or
more seriously, contribute to morbidity and mortality if not treated with proper interventions.
1,2,5,7,8,11,38
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APPENDIX B
LIST OF TABLES
Table 1. Demographic and clinical characteristics of pediatric oncology patients (N=40)

Age, years
Mean (SD)

13.7 (3.1)

Median (range)

14 (7-18)

Gender
Female

18 (45)

Male

22 (55)

Diagnosis
Brain Tumor

10 (25)

Leukemia

6 (15)

Lymphoma

4 (10)

Solid Tumor

20 (50)

BMI, kg/m2
Mean (SD)
Median (range)

21.7 (6.1)
19.4 (14.0-38.3)

REE measured by Metabolic Cart
Mean (SD)
Median (range)

1,385 (336)
1,368 (910-2,503)

REE measured by MedGem n=36
Mean (SD)
Median (range)

1,208 (298.6)
1,230 (640-1,980)

REE measured by WHO Energy
Equation
Mean (SD)

1,538 (349.1)

Median (range)
1,501 (913-2,415)
Abbreviations: BMI, Body Mass Index; REE, Resting Energy Expenditure.
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Table 2. Results of two-way ANOVA
D
F

Type I SS

Mean
Square

F
Value

P

Subject

39 10517962.7 269691.35
6

11.06

<0.0001

Method

2 2016457.12 1008228.56 41.35

<0.0001

Table 3. Pairwise comparisons of REE obtained by three methods
MedGe
m
Cart

Equatio
n

<0.0001 <0.0001

MedGem

<0.0001

Table 4. Percent difference from the Metabolic Cart method

Method

N

Mean
Percent
Difference

MedGem vs.
Cart

36

-11.9%

95% CI for
Mean Percent
Difference

90% CI for
Mean Percent
Difference

-17.3% to -6.6% -16.4% to -7.5%

Equation vs.
40
12.4%
7.5% to 17.2%
Cart
Abbreviations: CI, Confidence Interval.
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8.4% to 16.4%

P –value for
Equivalence
0.764
0.838
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